Clinically-Relevant Biomarker Strategies in Drug Development and the Potential of Machine-Learning for Biomarker Assessment, Upcoming Webinar Hosted by Xtalks
Summary
Biomarker quantification plays an integral role in the drug development process, providing guidance for downstream decision-making that has shown to correlate positively with clinical trial success. It is also worth considering the prospect of applying machine-learning to biomarker assessment, which promises improved patient stratification of treatment response to drive drug development. Join experts from Synexa Life Sciences, Justin Devine, CMO & Interim CSO; and Nicholas Woudberg, Scientific Engagement and Proposals Manager, for the live webinar on Friday, November 18, 2022, at 10am EST (4pm CET/EU-Central). Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.)